These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


343 related items for PubMed ID: 17525281

  • 1. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation.
    Nakamura K, Yamagishi S, Matsui T, Yoshida T, Takenaka K, Jinnouchi Y, Yoshida Y, Ueda S, Adachi H, Imaizumi T.
    Am J Pathol; 2007 Jun; 170(6):2159-70. PubMed ID: 17525281
    [Abstract] [Full Text] [Related]

  • 2. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.
    Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T.
    J Biol Chem; 2006 Jul 21; 281(29):20213-20. PubMed ID: 16707486
    [Abstract] [Full Text] [Related]

  • 3. Pigment epithelium-derived factor (PEDF) inhibits angiotensin II-induced smooth muscle cell proliferation through its anti-oxidative properties.
    Yamagishi S, Matsui T, Nakamura K, Imaizumi T.
    Protein Pept Lett; 2007 Jul 21; 14(6):615-7. PubMed ID: 17627605
    [Abstract] [Full Text] [Related]

  • 4. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
    Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T.
    Cell Tissue Res; 2005 Jun 21; 320(3):437-45. PubMed ID: 15846509
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Baicalin inhibits PDGF-BB-stimulated vascular smooth muscle cell proliferation through suppressing PDGFRβ-ERK signaling and increase in p27 accumulation and prevents injury-induced neointimal hyperplasia.
    Dong LH, Wen JK, Miao SB, Jia Z, Hu HJ, Sun RH, Wu Y, Han M.
    Cell Res; 2010 Nov 21; 20(11):1252-62. PubMed ID: 20661261
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: a possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes.
    Takenaka K, Yamagishi S, Matsui T, Nakamura K, Jinnouchi Y, Yoshida Y, Ueda S, Katsuki Y, Katsuda Y, Imaizumi T.
    Atherosclerosis; 2008 Mar 21; 197(1):25-33. PubMed ID: 17850801
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
    Jinnouchi Y, Yamagishi S, Matsui T, Takenaka K, Yoshida Y, Nakamura K, Ueda S, Imaizumi T.
    Brain Res; 2007 Sep 05; 1167():92-100. PubMed ID: 17692294
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C.
    Circ Res; 2009 Feb 27; 104(4):476-87. PubMed ID: 19150885
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PGC-1alpha attenuates neointimal formation via inhibition of vascular smooth muscle cell migration in the injured rat carotid artery.
    Qu A, Jiang C, Xu M, Zhang Y, Zhu Y, Xu Q, Zhang C, Wang X.
    Am J Physiol Cell Physiol; 2009 Sep 27; 297(3):C645-53. PubMed ID: 19553562
    [Abstract] [Full Text] [Related]

  • 15. Cordycepin attenuates neointimal formation by inhibiting reactive oxygen species-mediated responses in vascular smooth muscle cells in rats.
    Won KJ, Lee SC, Lee CK, Lee HM, Lee SH, Fang Z, Choi OB, Jin M, Kim J, Park T, Choi WS, Kim SK, Kim B.
    J Pharmacol Sci; 2009 Mar 27; 109(3):403-12. PubMed ID: 19305122
    [Abstract] [Full Text] [Related]

  • 16. Carvacrol inhibits atherosclerotic neointima formation by downregulating reactive oxygen species production in vascular smooth muscle cells.
    Lee KP, Sudjarwo GW, Jung SH, Lee D, Lee DY, Lee GB, Baek S, Kim DY, Lee HM, Kim B, Kwon SC, Won KJ.
    Atherosclerosis; 2015 Jun 27; 240(2):367-73. PubMed ID: 25875388
    [Abstract] [Full Text] [Related]

  • 17. Pigment epithelium-derived factor (PEDF) blocks angiotensin II-induced T cell proliferation by suppressing autocrine production of interleukin-2.
    Yamagishi S, Kikuchi S, Nakamura K, Matsui T, Takeuchi M, Inoue H.
    Med Chem; 2006 May 27; 2(3):265-9. PubMed ID: 16948472
    [Abstract] [Full Text] [Related]

  • 18. Pigment epithelium-derived factor reduces the PDGF-induced migration and proliferation of human aortic smooth muscle cells through PPARγ activation.
    Wang SH, Liang CJ, Wu JC, Huang JJ, Chien HF, Tsai JS, Yen YS, Tseng YC, Lue JH, Chen YL.
    Int J Biochem Cell Biol; 2012 Feb 27; 44(2):280-9. PubMed ID: 22074662
    [Abstract] [Full Text] [Related]

  • 19. Nuclear Focal Adhesion Kinase Controls Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia Through GATA4-Mediated Cyclin D1 Transcription.
    Jeong K, Kim JH, Murphy JM, Park H, Kim SJ, Rodriguez YAR, Kong H, Choi C, Guan JL, Taylor JM, Lincoln TM, Gerthoffer WT, Kim JS, Ahn EE, Schlaepfer DD, Lim SS.
    Circ Res; 2019 Jul 05; 125(2):152-166. PubMed ID: 31096851
    [Abstract] [Full Text] [Related]

  • 20. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.
    Yamagishi S, Inagaki Y, Nakamura K, Abe R, Shimizu T, Yoshimura A, Imaizumi T.
    J Mol Cell Cardiol; 2004 Aug 05; 37(2):497-506. PubMed ID: 15276019
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.